Market Valuation & Earnings Multiples
Market capitalization, P/E ratios, and enterprise value
Market Cap885.25B
Enterprise Value938.41B
Trailing P/E35.62
Forward P/E17.55
LLY
(NYSE)Eli Lilly and Company
$1,021.41-- (--)
Loading... - Market loading
Eli Lilly and Company (LLY) Key Statistics & Financial Metrics
Complete stock analysis with 40+ metrics: valuation ratios, profitability margins, financial health indicators, and dividend data.
Stock Valuation Metrics
Market value, earnings multiples, and pricing ratios
Price-Based Ratios
Valuation ratios based on stock price
Price/Sales (ttm)12.46
Forward Price/Sales8.45
Price/Book (mrq)28.86
Price/Tangible Book (mrq)50.88
Price/FCF (ttm)67.31
Price/OCF (ttm)43.96
PEG Ratio0.28
Enterprise Value Ratios
EV-based valuation multiples
EV/Revenue12.99
EV/Earnings37.13
EV/EBITDA24.81
EV/EBIT26.38
EV/FCF70.16
Stock Price
Current price, 52-week range, and moving averages
Current Price$1,021.41
1-Day Change-1.67%
52-Week High$1,133.95
52-Week Low$623.78
52-Week Change27.98%
YTD Change-8.54%
1-Year Change30.85%
50-Day MA$939.52
200-Day MA$918.02
Avg Volume (30 day)3.16M
Share Statistics
Outstanding shares, float, and per-share metrics
Shares Outstanding895.92M
Book Value per Share$34.82
Net Cash per Share$-42.51
FCF per Share$14.93
Analyst Price Targets & Consensus
Wall Street analyst ratings and 12-month price targets (90 days)
Price Target$1,209.00
Target Upside/Downside18.37%
Analyst ConsensusStrong Buy
Analyst Count6
Profitability & Financial Performance
Profit margins, return metrics, and earnings analysis
Profit Margins
Profitability margins across income statement
Gross Margin82.83%
EBITDA Margin (ttm)52.34%
EBIT Margin (ttm)49.23%
Operating Margin (ttm)47.30%
Pretax Margin (ttm)43.08%
Profit Margin (ttm)34.99%
FCF Margin (ttm)18.51%
Return on Investment Metrics
ROE, ROA, ROIC, and capital efficiency ratios
Return on Equity (ttm)81.02%
Return on Assets (ttm)21.68%
Return on Invested Capital (ttm)41.69%
Return on Capital Employed (ttm)44.49%
Income Statement (TTM)
Trailing twelve months revenue and earnings
Revenue72.25B
Gross Profit59.84B
Operating Income34.17B
Pretax Income31.13B
Net Income25.28B
EBITDA37.82B
EBIT35.57B
Diluted EPS$28.14
Cash Flow (TTM)
Operating cash flow and free cash flow metrics
Operating Cash Flow20.48B
Capital Expenditures7.10B
Free Cash Flow13.38B
Growth Rates (YoY)
Year-over-year growth metrics
Revenue Growth47.44%
Dividend Growth15.36%
Financial Health & Dividends
Balance sheet analysis, debt ratios, and dividend metrics
Assets & Cash
Total assets and cash positions
Total Assets (mrq)116.58B
Cash & Securities (mrq)5.28B
Net Cash (mrq)-38.09B
Net Cash per Share$-42.51
Debt & Liabilities
Liabilities, debt, equity, and working capital
Total Debt (mrq)43.37B
Working Capital (mrq)18.20B
Total Equity (mrq)31.20B
Book Value per Share$34.82
Liquidity & Leverage
Liquidity, leverage, and debt coverage ratios
Current Ratio (mrq)1.50
Quick Ratio (mrq)1.10
Debt/Equity (mrq)1.39
Debt/EBITDA (ttm)1.15
Debt/FCF (ttm)3.24
Dividend History & Payout Analysis
Dividend yield, payout ratios, and growth metrics
Dividend per Share (TTM)$6.46
Dividend Yield0.65%
Payout Ratio (Earnings)22.95%
Payout Ratio (FCF)43.27%
Dividend Growth (YoY)15.36%
Years of Dividend Growth11
Ex-Dividend DateMay 15, 2026
Pay DateJun 10, 2026
Dividend FrequencyQuarterly
Yield Metrics
Earnings, FCF, buyback, and shareholder yields
Earnings Yield2.81%
FCF Yield1.49%
Buyback Yield0.58%
Total Shareholder Yield1.23%
Financial Health Scores
Risk assessment and quality metrics
Altman Z-Score4.28
Piotroski F-Score7/9
Dividend Score66.32
Fair Value & Intrinsic Value
Lynch fair value, Graham number, and valuation models
Lynch Fair Value$3,598.68
Lynch Upside/Downside264.21%
Graham Number$148.49
Graham Upside/Downside-84.97%
Frequently Asked Questions About Eli Lilly and Company Statistics
What are the key financial metrics for LLY?
Eli Lilly and Company (LLY) statistics include 40+ financial metrics organized into valuation ratios (P/E, P/S, P/B, PEG), profitability margins (gross, operating, net), return metrics (ROE, ROA, ROIC), and financial health indicators. These are updated regularly based on the latest filings and market data.
What is LLY's valuation analysis?
The valuation section covers market capitalization, earnings multiples like trailing and forward P/E, price-based ratios (P/S, P/B, Price/FCF), and enterprise value ratios (EV/EBITDA, EV/Revenue, EV/FCF). Compare these against sector averages to assess whether Eli Lilly and Company is overvalued or undervalued.
How do I read LLY's profitability ratios?
Eli Lilly and Company's profitability is measured through profit margins (gross, EBITDA, operating, net) and return metrics (ROE, ROA, ROIC, ROCE). Higher margins indicate better cost control, while higher returns show efficient capital deployment. The income statement and cash flow sections provide the underlying revenue and earnings data.
What do LLY's debt ratios indicate?
The financial health section shows Eli Lilly and Company's leverage through debt-to-equity, debt-to-assets, debt-to-EBITDA, and debt-to-FCF ratios, plus liquidity via the current and quick ratios. Lower debt ratios and higher liquidity ratios generally indicate stronger financial stability and lower default risk.
What is LLY's dividend analysis?
The dividend section covers Eli Lilly and Company's dividend yield, payout ratios (earnings-based and FCF-based), year-over-year dividend growth, years of consecutive growth, ex-dividend and pay dates, and payment frequency. The yield metrics section also includes earnings yield, FCF yield, buyback yield, and total shareholder yield.